News

According to the report of the international news agency, at the time when the wedding ceremony was being held, there were more than 1000 people in the ceremony, including DJ Steven Nabeel and his fiancee.

According to the report of the British Broadcasting Corporation, Steven Nabeel cried while holding a picture of his fiancee, saying that my fiancee was also one of the unfortunate people who fell victim to the accident.

Steven Nabil said that when the wedding ceremony was being held in the hall, he had gone out of the hall for some work. Sent your photos.

Steven Nabil said that I had not reached the hall when my fiancee called me, she said that I am going to die, take care of yourself, I love you so much, I asked her what happened. said that the hall is on fire and full of smoke, I told him I am coming.

“When I reached the hall, the smoke was so thick that I was suffocating,” Nabeel said, crying. When I reached, I saw my fiance lying dead on the ground with a phone in her hand.

According to foreign media reports, the official report said that the fire in the wedding hall was accidental and unintentional.

The report states that 900 people were allowed to enter a building that had a capacity of only 400 people.

According to the Iraqi interior minister, people were trapped in the doors on their way out because the doors were too small and the fire was spreading quickly, causing many lives to be lost.

US President Joe Biden of Corona The test came back positive on Wednesday, but his symptoms are mild. Immediately following the test, he admitted that he would consider dropping out of the presidential race if doctors diagnosed him with a serious medical condition.

In a brief tweet on his X account on Thursday, the US president wrote: ‘I’m sick.’

In his message, Pakistani Prime Minister Shahbaz Sharif expressed his best wishes for the speedy and complete recovery of US President Joe Biden from Covid.

According to news agency AFP, the 81-year-old Democratic candidate cut short his campaign in Las Vegas following testing positive for the coronavirus and went into self-isolation at his home on the Delaware coast. At the time, he told reporters: ‘I feel good.’

Joe Biden thanked well-wishers on X, saying: ‘I will self-isolate while I recover and continue to work for the American people in the meantime.’

The US president’s positive coronavirus test comes at a time when a poor performance in a debate once morest Republican rival Donald Trump has raised concerns regarding his health and some Democrats have called for him to drop out.

It’s the latest development in an already tumultuous race for the White House, which comes days following Donald Trump narrowly escaped an assassination attempt at a campaign rally.

After testing positive, Joe Biden reportedly had to cancel an address to a union representing Latino workers, who will be key to his campaign. He attended an election function and gave a radio interview on the same day.

Karen Jean-Pierre, a spokeswoman for the US president, said Biden, who was given the vaccine and booster, is now taking the Covid-19 drug Paxilvid and is “fully performing his duties” while in isolation.

White House doctor Kevin O’Connor said Joe Biden had complained of a runny nose, cough and “anxiety” and had tested positive following campaigning.

Kevin O’Connor added that his symptoms were mild and his breathing rate, temperature and blood oxygen levels were all normal.

US President Joe Biden (following testing positive for coronavirus) was seen walking from his limousine to his plane in Las Vegas without a mask. When asked how he felt, he said: ‘Well, I feel good.’

Unidos Union for Latino Workers President Janet Murguia briefed attendees on the U.S. president’s coronavirus diagnosis shortly before the White House announcement.

He said: ‘I just got off the phone with President Biden and he expressed his disappointment in not being able to join us this followingnoon.’

People waiting for the US President’s speech said that despite the diagnosis of Corona, they are not worried regarding Joe Biden’s health.

‘I think he is strong and will recover soon,’ Ann Villagott told AFP.

But Biden’s illness comes at a time when concerns regarding the health of the oldest US president in US history have intensified.

During a radio interview in Las Vegas on Tuesday, when asked what would cause him to reconsider a presidential run, Biden said: ‘If I had a medical problem like that Come, if someone, if a doctor comes and says, ‘You have this problem, that problem.’

Joe Biden has so far denied dropping out of the presidential race and blamed a bad cold and jet lag for the failure of his debate with Trump, during which he appeared tired and confused.

But he suffered a major blow on Wednesday when the most high-profile Democrat ever, Adam Schiff, urged Biden to “pass the (presidential) torch to someone else.”

In a statement to the Los Angeles Times, Schiff said that a second Trump presidency would undermine the foundation of our democracy and that I am deeply concerned regarding whether President Joe Biden can defeat Donald Trump in November. .

After that, the American broadcaster ABC News reported that Chuck Schumer, the majority leader of the Democratic Party in the Senate, told Biden that “it will be better for the country if he withdraws.”

However, a spokesman for Chuck Schumer dismissed the report, saying that ‘unless ABC’s source is Senator Chuck Schumer or President Joe Biden, this reporting is pure speculation.’

“Schumer took his group’s ideas directly to President Biden on Saturday,” he added.

Meanwhile, Biden’s campaign used the president’s illness as a fundraising opportunity. His X account said ‘I’m sick’ and then said: ‘Elon Musk and his rich friends are trying to buy this election.’

Elon Musk said on Saturday that he was supporting Trump following an assassination attempt at a rally in Pennsylvania.

Joe Biden insists that Democratic voters support him, but a poll by the Associated Press and the NORC Center for Public Affairs Research found that nearly two-thirds of voters want him out of the race. .

• A group of scientists discovered the mechanism by which cobra venom causes necrosis and have developed an antidote based on heparin | Photo by Anil sharma in Pixabay

Snakebites are estimated to kill around 138,000 people a year, mostly in sub-Saharan Africa and South and Southeast Asia. Now, a scientific team has discovered that a commonly used anticoagulant, heparin, can be used as a cheap antidote to cobra venom.

The “promising” research, which appears on the cover of the journal Science Translational Medicine, was carried out on cells and mice by scientists from the University of Sydney (Australia) and the Liverpool School of Tropical Medicine (England).

Cobras kill thousands of people worldwide each year and many more are severely maimed by venom necrosis (death of tissue and cells), which can lead to amputation. Current anti-venom treatment is expensive and does not effectively treat flesh necrosis, a statement from Sydney said.

Share on

Molecular dissection of venom

The team, which also includes scientists from Canada and Costa Rica, used CRISPR gene-editing technology to identify ways to block the venom of the red-necked and black-necked spitting cobra and was able to repurpose heparin and related drugs, showing that they can stop necrosis.

Researchers used CRISPR to find the human genes that cobra venom needs to cause necrosis. One of the targets cobra venom needs are the enzymes needed to produce the molecules heparan and heparin, which are found in many human and animal cells.

Heparan is found on the surface of cells and heparin is released during an immune response; their similar structure means that the venom can bind to both. The team used this knowledge to make an antidote capable of stopping necrosis in human cells and mice.

Unlike current methods for cobra bites, which use 19th-century technologies, heparinoid drugs act as a ‘decoy’ antidote. By flooding the bite site with heparin sulfate (decoy) or related heparinoid molecules, the antidote can bind to and neutralize the tissue-damaging toxins in the venom.

Three of the heparins used in the study are the same drugs currently used to prevent blood clots. All are already approved as anticoagulants, including the most effective heparinoid tested (tinzaparin), Nicholas Casewell of the Liverpool School of Tropical Medicine told EFE.

“Heparinoids are available for subcutaneous use, so we envision these molecules being injected close to the bite site in the community setting, where snakebite occurs.”

Currently, patients have to travel many hours to reach a hospital where they can receive antivenom treatment; “our hope is to be able to use heparinoids much earlier following a bite to reduce the severity of the envenomation,” adds Casewell.

For this researcher, the findings are interesting because current antivenoms are largely ineffective once morest severe local envenomation.

A challenge for the WHO

Snakebites kill up to 138,000 people a year and 400,000 more suffer long-term following-effects. Although the number of people affected by cobras is unclear, in parts of India and Africa, cobras account for the majority of snakebites.

The World Health Organization has identified bites from these reptiles as a priority in its program to combat neglected tropical diseases and announced the ambitious goal of halving the global burden of these bites by 2030.

The compounds do not require refrigeration like most antibody-based antivenoms, making heparinoids particularly useful in remote regions lacking medical infrastructure, the journal summarizes.

For now, there are no plans for a clinical trial with humans. “This is our hope for the next phase of this work, first we have to get funding (…),” Casewell told EFE, who nevertheless points out that heparin molecules have already been subjected to clinical trials for uses other than snake bites.

“Following the success of human trials, it might be rolled out relatively quickly and become a cheap, safe and effective drug for treating cobra bites,” concludes Tian Du of the University of Sydney.

With information from EFE

Related news